Evidence map›Paper›PMID 23708052›Full record

ArticleJournal of the National Cancer Institute2013

Height as an explanatory factor for sex differences in human cancer.

Roland B Walter, Theodore M Brasky, Sarah A Buckley, John D Potter, Emily White

Open access · greenAbstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 5 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 5 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Adult-Attained Height and Colorectal Cancer Risk: A Cohort Study, Systematic Review, and Meta-Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Height and kidney cancer risk: a meta-analysis of prospective studies.Journal of cancer research and clinical oncology · 2015
    Pooled it
  6. Trial
  7. Article
  8. Body height and the excess cancer risk in men.International journal of cancer · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Height as a mediator of sex differences in cancer risk.Annals of oncology : official journal of the European Society for Medical Oncology · 2020
    Article
  16. Article
  17. Article
  18. The epidemiology of lung cancer.Translational lung cancer research · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Roland B WalterClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. rwalter@fhcrc.org
Theodore M Brasky
Sarah A Buckley
John D Potter
Emily White
Fred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Established Investigator Award Anti-Inflammatory Exposures in Cancer PreventionK05CA154337 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2011 to 2015
$637k
NCI NIH HHS K05 CA154337NCI NIH HHS K05-CA154337NCI NIH HHS P30 CA015704NCI NIH HHS P30-CA15704-35S6
6 · The paper itself

Abstract

backgroundMost cancers occur more frequently in men. Numerous explanations for this excess risk have been proposed, yet no study has quantified the degree to which height explains the sex difference even though greater height has been associated with increased risk for many cancers.

methodsDuring the period from 2000 to 2002, 65308 volunteers aged 50 to 76 years were recruited to the Vitamins And Lifestyle (VITAL) study. Cancers of shared anatomic sites (n = 3466) were prospectively identified through 2009 through the Surveillance, Epidemiology, and End Results cancer registry. Age- and race-adjusted hazard ratios (HRs) for the associations between sex and incident cancers were estimated using Cox proportional hazards models, with and without adjustment for height and height squared as measures of body size.

resultsMen had a 55% increased risk of cancer at shared sites (HR = 1.55; 95% confidence interval [CI] = 1.45 to 1.66). When height was accounted for, 33.8% (95% CI = 10.2% to 57.3%) of the excess risk for men was explained by the height differences between sexes. The proportion mediated by height was 90.9%, 57.3%, and 49.6% for kidney, melanoma, and hematologic malignancies, respectively, with little evidence that height mediates the sex difference for gastrointestinal tract, lung, and bladder cancers. For comparison, more than 35 lifestyle and medical risk factors only explained 23.1% of the sex difference in cancer risk at shared sites.

conclusionsHeight is an important explanatory factor for the excess risk for men for many shared-site cancers. This suggests that some of the excess risk is due to factors associated with height (eg, number of susceptible cells in a specific organ or growth-influencing exposures in childhood).

Indexed as

Body HeightAgedAlcohol DrinkingFeeding BehaviorFemaleGonadal Steroid HormonesHumansIncidenceLife StyleMaleMiddle AgedNeoplasmsOccupational ExposureOdds RatioProportional Hazards ModelsRisk FactorsGonadal Steroid Hormones

Identifiers

PMID23708052
PMCPMC3687370
OpenAlexW2095925574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.